Biomarkers for detection and surveillance of bladder cancer.
about
Potential new urinary markers in the early detection of bladder cancer.FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy.Aminopeptidase activities as prospective urinary biomarkers for bladder cancer.Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladderFluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic studyUrinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.Developing urinary metabolomic signatures as early bladder cancer diagnostic markersA pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace.Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer.Bladder cancer screening in aluminum smelter workersThe direct anti-cancer effect of a single instillation of epirubicin after transurethral resection of bladder tumor for non-muscle-invasive bladder cancerOrgan Specific Tumor Markers: What's New?Epigenetic alterations in bladder cancer and their potential clinical implications.Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine.Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancerNMP22 is predictive of recurrence in high-risk superficial bladder cancer patientsDiagnostic utility of double immunostaining of a urine cytology preparation for cytokeratin 20/p53 expression in a young woman with micropapillary urothelial carcinoma of the renal pelvis presenting as an unknown primary malignancyPoint-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria.Identification of genes correlated with early-stage bladder cancer progressionDiagnostic and Prognostic Significance of Serum and Tissue Galectin 3 Expression in Patients with Carcinoma of the BladderMicroplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer.Investigating Colorimetric Protein Array Assay Schemes for Detection of Recurrence of Bladder Cancer.Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?
P2860
Q33657098-3C21D4E0-9FC3-44D6-97B0-40978B28A40DQ33745140-5448E075-DBD7-473C-9861-B8D51CD9C74AQ33762931-747E8604-0C0D-49E8-847B-5FA636D11F66Q33772333-C88ED21A-B7C4-45BB-84F2-4FDE8E4227F6Q33929637-B951A673-1B50-407C-82EE-8DA3F99EA82AQ34059983-490A99D4-454A-4233-8A35-C82E94772B93Q34361348-7A891E6F-26A6-407F-9F56-1ACEB52D3B3CQ34401768-D0645CEB-867B-437A-A539-336280DA9410Q34802622-76966BD5-AE90-4B6C-8829-CFC096DA1478Q34828645-B671D358-1CE7-4DE1-966D-B93508FC9682Q34957287-F9222C1F-DD53-476E-B22B-2D737119B39BQ35219579-7340BE36-97D1-4880-A678-153655BFB83AQ35775435-9A51292E-1C5F-4D7E-8029-777190236170Q35980584-DFD166C6-AFE5-4D1F-81E1-11391E433171Q36095721-A49C161F-C393-4D95-9990-749482521D26Q36387900-F576CABA-ADC8-40D4-916B-DB2229B4436FQ36556271-1ECF45F4-5DBA-496B-BD81-8E6008A17B45Q37085946-B947CA16-9078-4007-A97F-C1B5E7989D54Q37472494-D1D6F3C5-0359-4863-8EB0-94F88D38B9B1Q37472535-BCD8C71C-90B9-4413-9D67-21998EEB14F6Q39480653-7873281B-1FD5-4EE9-8BA6-501C9DE3ABDFQ40897221-F392E55B-7E52-4019-84C6-A6187CCD90B9Q41661749-51E8BBE1-083E-418D-964A-E029150964ACQ41701956-3149CFCD-6BAD-4167-BE69-D5FD3F753D65Q48175687-4FCDE7BC-6CBF-4AB5-96EA-C9923FD5450BQ55286854-807D5BD3-7B9E-4384-93B9-CBD509030B5B
P2860
Biomarkers for detection and surveillance of bladder cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Biomarkers for detection and surveillance of bladder cancer.
@ast
Biomarkers for detection and surveillance of bladder cancer.
@en
type
label
Biomarkers for detection and surveillance of bladder cancer.
@ast
Biomarkers for detection and surveillance of bladder cancer.
@en
prefLabel
Biomarkers for detection and surveillance of bladder cancer.
@ast
Biomarkers for detection and surveillance of bladder cancer.
@en
P2093
P2860
P356
P1476
Biomarkers for detection and surveillance of bladder cancer
@en
P2093
Jordan R Steinberg
Lorne I Budman
Wassim Kassouf
P2860
P304
P356
10.5489/CUAJ.600
P577
2008-06-01T00:00:00Z